Implementation of a two-plasmid CRISPR/Cas9 system in Lactobacillus plantarum : a new approach in the development of a novel vaccine against Mycobacterium tuberculosis
Year: 2018
Type: dissertation
Abstract: Tuberculosis (TB) is the leading cause of deaths from a single infectious agent, and in 2017 1.7 million people died from TB. To date the only available vaccine against the disease is the bacille Calmette-Guèrin (BCG) vaccine. The BCG vaccine does not ensure full protection against the mature form of TB, and is not recommended to immunocompromised patients. Therefore, a new and more effective vaccine is urgently needed. This study is a part of a larger project with a long-term goal to develop mucosal vaccines, utilizing the lactic acid bacteria (LAB) Lactobacillus plantarum as delivery vectors of antigens. LAB occurs in a wide range of habitats, ranging from food products such as fruit and dairy, but also human mucosal surfaces such as the small intestine and colon. Lactobacilli are natural inhabitants of the human gastro intestinal tract (GIT) and are generally regarded as safe (GRAS). Some Lactobacilli are believed to have probiotic properties and live in close association with the intestinal epithelium and have shown immunomodulatory effects in human. These properties make Lactobacilli, such as L. plantarum, an ideal candidate as a delivery vector of immunogens. In the present study, pSIP inducible vectors for cytoplasmic and membrane anchoring of the TB fusion antigen Ag85B_TB10.4 in L. plantarum were constructed, and production of surface localized antigen was confirmed. Currently, the production of the antigen is plasmid based. To reduce the number of heterologous genes of the recombinant L. plantarum, it is desirable to integrate the antigen production into genome of the bacteria. In this thesis, methods for utilization of the CRISPR/Cas system was attempted developed for integration of the antigen. To simplify integration, as it is independent of helper genes unlike the pSIP system, construction of vectors for constitutive production of Ag85B_TB10.4 were attempted. Evaluation of the functionality of the CRISPR/Cas system in L. plantarum was performed through experiments of gene editing, replacement and depletion with Cas9, Cas9D10A and dCas9. In conclusion, Ag85B_TB10.4 was successfully anchored to the cell membrane of L. plantarum by using the pSIP system, while construction of a vector for constitutive production of Ag85B_TB10.4 failed. Conceivably due to toxicity of the constitutive production of the antigen in E. coli. The CRISPR/dCas9 system was successfully developed, and reduction of transcripts of target genes was confirmed by ddPCR. Gene editing and exchange with Cas9 and Cas9D10A gave the expected phenotype, but no mutations were detected from DNA sequencing. These methods require further optimisations.
Source: NVA (Nasjonalt vitenarkiv)
Author: Kamilla Wiull
Institution: Norwegian University of Life Sciences
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2965019438
